250 related articles for article (PubMed ID: 4470836)
1. Intermittent chemotherapy of pulmonary tuberculosis using rifampicin and isoniazed for primary treatment: the influence of various factors on the frequency of side-effects.
Eule H; Werner E; Winsel K; Iwainsky H
Tubercle; 1974 Mar; 55(1):81-9. PubMed ID: 4470836
[No Abstract] [Full Text] [Related]
2. [Intermittent chemotherapy of pulmonary tuberculosis using rifampicin and isoniazed for primary treatment: the influence of various factors on the frequency off side-effects].
Aubert MF; Beaucournu JC
Ann Parasitol Hum Comp; 1976; 51(1):143-56. PubMed ID: 937975
[TBL] [Abstract][Full Text] [Related]
3. Intermittent chemotherapy of pulmonary tuberculosis using rifampicin and isoniazid for primary treatment: the influence of various factors on the frequency of side-effects.
Eule H; Werner E; Winsel K; Iwainsky H
Tubercle; 1974 Mar; 55(1):81-9. PubMed ID: 4620295
[No Abstract] [Full Text] [Related]
4. [Side effects of various combinations of rifampin and isoniazid with ethambutol or streptomycin and pyrazinamide in short-term chemotherapy of newly-detected pulmonary tuberculosis].
Zierski M; Bek E
Pneumonol Pol; 1980 Jul; 48(7):469-79. PubMed ID: 7433146
[No Abstract] [Full Text] [Related]
5. [Clinical effects of rifampicin for pulmonary tuberculosis patients. 1. Comparison of rifampicin-ethambutol-isoniazid with streptomycin-paraminosalcylic acid-isoniazid in the original treatment of pulmonary tuberculosis patients].
Kekkaku; 1971 Oct; 46(10):393-9. PubMed ID: 5147895
[No Abstract] [Full Text] [Related]
6. On the pharmacokinetics of rifampicin I: Influence of dosage and duration of treatment with intermittent administration.
Iwainsky H; Winsel K; Werner E; Eule H
Scand J Respir Dis; 1974; 55(4):229-36. PubMed ID: 4438983
[No Abstract] [Full Text] [Related]
7. Clinical effect of rifampicin-ethambutol isoniazid on untreated pulmonary tuberculosis.
Konno K; Oizumi K; Yamada S; Ogata K; Sato M
Sci Rep Res Inst Tohoku Univ Med; 1972 Sep; 19(2):68-72. PubMed ID: 4649624
[No Abstract] [Full Text] [Related]
8. Controlled therapeutic trial with the combination rifampicin-isoniazid given for six months to previously untreated patients with pulmonary tuberculosis.
Dubra F
Bull Int Union Tuberc; 1972 Feb; 47():37-40. PubMed ID: 4562016
[No Abstract] [Full Text] [Related]
9. [Proceedings: Rifampicin adverse effects in intermittent therapy].
Herrmann H; Eule H; Lau W; Kuhnert R; Fanter D; Kahlau U; Schönert E; Werner E
Z Erkr Atmungsorgane Folia Bronchol; 1973; 138(1):146-58. PubMed ID: 4491712
[No Abstract] [Full Text] [Related]
10. [Results of initial treatment of pulmonary tuberculosis using ethambutol, isonicotinic acid hydrazide and rifampicin].
Kesztele V; Niederkofler J
Wien Med Wochenschr; 1970 Jun; 120(25):473-5. PubMed ID: 5518004
[No Abstract] [Full Text] [Related]
11. Six-month isoniazid-rifampin treatment for pulmonary tuberculosis in children.
Reis FJ; Bedran MB; Moura JA; Assis I; Rodrigues ME
Am Rev Respir Dis; 1990 Nov; 142(5):996-9. PubMed ID: 2240853
[TBL] [Abstract][Full Text] [Related]
12. Intermittent rifampicin treatment of tuberculosis.
Riska N; Mattson K
Scand J Respir Dis Suppl; 1973; 84():140-4. PubMed ID: 4522069
[No Abstract] [Full Text] [Related]
13. [Clinical evaluation of Rifampicin in pulmonary tuberculosis. 2. A controlled trial on the clinical effects of chemotherapy with Rifampicin-INH-PAS and SM-INH-PAS for treatment of original cases of pulmonary tuberculosis].
Donomae I; Fujita S; Gomi J; Hibino S; Horai Z
Kekkaku; 1970 Aug; 45(8):257-62. PubMed ID: 4918166
[No Abstract] [Full Text] [Related]
14. [Controlled trial of isoniazid.rifampicin.ethambutol regimen and isoniazid.rifampicin.pyrazinamide regimen in the primary chemotherapy for pulmonary tuberculosis (author's transl)].
Kekkaku; 1980 Jan; 55(1):7-13. PubMed ID: 6988627
[No Abstract] [Full Text] [Related]
15. Controlled clinical evaluation of three intermittent regimens employing low-dosage schedules of rifampicin in original treatment of pulmonary tuberculosis. Preliminary data on effectiveness and side effects.
Nitti V
Scand J Respir Dis Suppl; 1973; 84():180-5. PubMed ID: 4593266
[No Abstract] [Full Text] [Related]
16. Fibrinogen and antithrombin III blood levels fluctuations during isoniazid or isoniazid plus rifampicin administration.
Farmakis M; Travlou O; Aroni S; Fertakis A
Arzneimittelforschung; 1992 Aug; 42(8):1041-4. PubMed ID: 1418078
[TBL] [Abstract][Full Text] [Related]
17. [Side effects of rifampicin in the treatment of chronic pulmonary tuberculosis by the intermittent method].
Kost A
Pol Tyg Lek; 1975 Mar; 30(13):557-8. PubMed ID: 1121469
[No Abstract] [Full Text] [Related]
18. Drugs for tuberculosis.
Med Lett Drugs Ther; 1995 Aug; 37(954):67-70. PubMed ID: 7616907
[No Abstract] [Full Text] [Related]
19. Treatment of pulmonary tuberculosis with short course isoniazid-rifampicin regimen compared with standard regimen in ambulatory pediatric clinic.
Trastotenojo MS; Wiroreno B; Santosa ; Soemantri AG; Hendarto T; Singgih Y
Paediatr Indones; 1983; 23(11-12):240-9. PubMed ID: 6678404
[No Abstract] [Full Text] [Related]
20. [Therapy of tuberculosis in the adult].
Schrappe M; Wassermann K; Kroegel C
Med Klin (Munich); 1995 Apr; 90(4):229-30. PubMed ID: 7776936
[No Abstract] [Full Text] [Related]
[Next] [New Search]
